TII
14.12.2020 10:21:12 CET | Business Wire | Press release
Technology Innovation Institute (TII), the applied research pillar of Advanced Technology Research Council (ATRC), today announced the formation of a board of advisors at Cryptography Research Centre (CRC). The new board of advisors comprises global experts in the field of cryptography.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005303/en/
The appointments follow a series of rapid announcements at Technology Innovation Institute since the first Advanced Technology Research Council board meeting in August 2020.
CRC is one of the initial seven dedicated centres at TII and it is also one of the few global centres bringing together theoretical and applied cryptographers in a research-oriented setting. The cryptographers collaborate on breakthrough research projects that lead to innovative outcomes in cryptography. Spanning fields from post quantum cryptography (PQC), lightweight cryptography, cryptanalysis, cryptographic protocols, hardware-based cryptography, confidential computing, amongst others, the distinguished board of advisors will guide efforts to develop breakthrough technologies for global impact, reinforcing the UAE’s position as a global hub for innovation and R&D.
The Board of Advisors includes: Prof Joan Daemen , Professor of Symmetric Cryptography at Radboud University in The Netherlands, who co-designed the Rijndael cipher that was selected as the Advanced Encryption Standard (AES) and is also one of the co-designers of the Keccak (SHA-3) cryptographic algorithm; Prof Lejla Batina , Professor of Hardware Cryptography at Radboud University, whose expertise is in applied cryptography and embedded systems security; Dr Guido Bertoni , CEO of Security Pattern, Italy, whose research areas include cryptographic algorithms, hardware-based cryptography, applied cryptography and embedded systems security. He is also a co-designer of the Keccak (SHA-3) cryptographic algorithm. Prof. Carlos Aguilar , Professor of ISAE SUPAERO in Toulouse University, France, a post quantum cryptographer and expert in secure cryptographic implementations and computational theory; Prof. Damien Stehlé , Professor in Computer Science at École Normale Supérieure de Lyon, France, whose focus areas are post quantum cryptography, computational theory and complex algebra; and Prof. Tim Güneysu, Professor of Security Engineering at Ruhr-University Bochum, Germany, who is an expert in secure hardware implementations, cloud cryptographic schemes and secure engineering.
CRC currently employs and collaborates with scientists in multiple crucial fields of cryptography. The experts are engaged in the full spectrum of fundamental and applied cryptography and cryptanalysis research.
Speaking on the board appointments, Dr Najwa Aaraj, Chief Researcher at CRC, said: “The success of any scientific and research-focused entity is led by its board of advisors as they support in setting the vision. By bringing together renowned experts, we are connecting global expertise in the field of cryptography.”
Dr Aaraj added: “Through the research undertaken at the Cryptography Research Centre, we are confident that Abu Dhabi and the UAE will pioneer breakthrough technologies that ensure even greater enhancements in high-priority cryptographic areas.”
TII is a pioneering global research and development centre that focuses on applied research and new-age technology capabilities. The Institute has seven initial dedicated research centres in quantum, autonomous robotics, cryptography, advanced materials, digital security, directed energy and secure systems. By working with exceptional talent, universities, research institutions and industry partners from all over the world, the Institute connects an intellectual community and contributes to building an R&D ecosystem in Abu Dhabi and the UAE. The Institute reinforces Abu Dhabi and the UAE’s status as a global hub for innovation and contributes to the broader development of the knowledge-based economy.
To know more about Cryptography Research Centre (CRC):
tii.ae/cryptographytii.ae/cryptography
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005303/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
